OmniAb, Inc

Founded in 1989, BiosPacific is a worldwide supplier for the immunodiagnostic kit manufacturer. The company specializes in developing, manufacturing and supplying its customers the critical antibody or antigen necessary to develop diagnostic assays. Its products include monoclonal antibody, affinity purified polyclonal antibody, purified native and recombinant protein antigen, conjugate and secondary antibody reagents. Product categories are cardiac and tumor markers, steroids, allergy, anemia, therapeutic drugs, and human serum proteins. BiosPacific is located in Emeryville, Calif.

Crystal Bioscience Inc., based in Emeryville, CA, specializes in therapeutic antibody discovery through its innovative OmniAb platform, offering partners access to a diverse range of antibody repertoires and advanced screening technologies. The company utilizes validated transgenic animals, including proprietary species such as the OmniRat, OmniMouse, and the world's first heavy chain-only transgenic chicken, to produce high-quality fully human antibodies for various therapeutic applications. With a collaborative approach and a scientifically robust team, Crystal Bioscience Inc. supports over 90 biopharmaceutical companies and research institutions in advancing clinical drug development. Their OmniAb technology promises to enhance the discovery process for next-generation therapeutics, ensuring partners benefit from unmatched expertise and cutting-edge methodologies. Generated from the website

KineMed Inc. is a leading biotech company based in Emeryville, CA, dedicated to accelerating drug development by collaborating with major pharmaceutical and biotechnology firms. Founded by inventor Marc Hellerstein in 2001, the company focuses on pathway-based drug discovery and development, offering data on target engagement, toxicity, and disease progression to optimize the process and reduce associated risks. Specializing in real-time insights into conditions such as metabolic disorders, cancer, and neurodegenerative diseases, KineMed enables the identification of active drug candidates preclinically and confirms their therapeutic efficacy. The company has played a significant role in expediting the drug development process, underscoring its commitment to innovation in medical diagnostics and therapeutics. Generated from the website